Literature DB >> 8113627

Assessment of the fibrogenetic activity in chronic pancreatitis. The role of circulating levels of extracellular matrix components.

J E Domínguez-Muñoz1, G Manes, M Büchler, P Malfertheiner.   

Abstract

Determination of circulating levels of extracellular matrix components has been proposed as a reliable method to assess the activity of fibrogenetic processes. Therefore, we aimed to analyze circulating levels of laminin, fibronectin, and procollagen III peptide (PIIIP) in patients with chronic pancreatitis (CP) and to correlate them with the morphological and functional stage, and duration of the disease. Thirty patients with CP and 18 healthy controls were studied. Serum PIIIP concentrations (RIA), but not fibronectin (RID) and laminin (RIA), were abnormally high in 8 patients with CP. No correlation was found between circulating levels of extracellular matrix components and both functional and morphological stage and duration of CP. Nevertheless, patients with elevated serum PIIIP levels tend to have a more advanced CP (morphological and functional changes) than those with normal levels after a similar duration of the disease. We hypothesize that whereas functional and morphological findings reflect the cumulative effect of chronic inflammation on the pancreas, serum PIIIP concentrations would reflect the activity of the fibrogenetic process within the gland at the time of sampling. The results shown in the present study may be considered a starting point for longitudinal studies that examine the relationship between serum PIIIP or other markers for fibrogenetic activity and evolution of CP.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8113627     DOI: 10.1007/BF02784934

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  28 in total

1.  Is the aminoterminal propeptide of type III procollagen degraded in the liver? A study of type III procollagen peptide in serum during liver transplantation in pigs.

Authors:  K D Bentsen; S Boesby; P Kirkegaard; C P Hansen; S L Jensen; K Hørslev-Petersen; I Lorenzen
Journal:  J Hepatol       Date:  1988-04       Impact factor: 25.083

2.  Radioimmunoassay of laminin in serum and its application to cancer patients.

Authors:  D G Brocks; H Strecker; H P Neubauer; R Timpl
Journal:  Clin Chem       Date:  1986-05       Impact factor: 8.327

3.  Sequential connective matrix changes in experimental acute pancreatitis. An immunohistochemical and biochemical assessment in the rat.

Authors:  L Uscanga; R H Kennedy; R Choux; M Druguet; J A Grimaud; H Sarles
Journal:  Int J Pancreatol       Date:  1987-02

4.  Follow-up of the serum levels of extracellular matrix components in acute and chronic pancreatitis.

Authors:  G Adler; J Kropf; E Grobe; A M Gressner
Journal:  Eur J Clin Invest       Date:  1990-10       Impact factor: 4.686

5.  Clinical utility of the serum pancreolauryl test in diagnosis and staging of chronic pancreatitis.

Authors:  J E Domínguez-Muñoz; O Pieramico; M Büchler; P Malfertheiner
Journal:  Am J Gastroenterol       Date:  1993-08       Impact factor: 10.864

6.  Distribution of basement membrane proteins in normal and fibrotic human liver: collagen type IV, laminin, and fibronectin.

Authors:  E Hahn; G Wick; D Pencev; R Timpl
Journal:  Gut       Date:  1980-01       Impact factor: 23.059

7.  Efficacy of serum laminin measurement for diagnosis of fibrotic liver diseases.

Authors:  J Kropf; A M Gressner; A Negwer
Journal:  Clin Chem       Date:  1988-10       Impact factor: 8.327

8.  Serum concentrations of laminin and aminoterminal propeptide of type III procollagen in relation to the portal venous pressure of fibrotic liver diseases.

Authors:  A M Gressner; W Tittor; A Negwer; K H Pick-Kober
Journal:  Clin Chim Acta       Date:  1986-12-30       Impact factor: 3.786

9.  Serum concentrations of the carboxyterminal cross-linking domain of procollagen type IV (NC1) and the aminoterminal propeptide of procollagen type III (PIIIP) in chronic liver disease.

Authors:  A Hayasaka; D Schuppan; K Ohnishi; K Okuda; E G Hahn
Journal:  J Hepatol       Date:  1990-01       Impact factor: 25.083

10.  The N-terminal propeptide of collagen type III in serum reflects activity and degree of fibrosis in patients with chronic liver disease.

Authors:  A Frei; A Zimmermann; K Weigand
Journal:  Hepatology       Date:  1984 Sep-Oct       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.